BioVie Inc
BIVI6.050USD
+0.020+0.33%
交易中 （美東）報價延遲15分鐘
112.03M總市值
虧損本益比TTM
關於 BioVie Inc 公司
BioVie Inc. 是一家臨牀階段公司，致力於開發藥物療法來治療慢性衰弱性疾病，包括肝病、神經系統和神經退行性疾病。在神經退行性疾病方面，該公司的候選藥物 bezisterim (NE3107) 可抑制細胞外信號調節激酶和轉錄因子核因子 kB 的炎症激活，以及相關的神經炎症和胰島素抵抗，但不能抑制細胞外單調節激酶 (ERK) 和活化 B 細胞的核因子 kappa 輕鏈增強子 (NFkB) 穩態功能（胰島素信號傳導和神經元生長和存活）。炎症和胰島素抵抗都是阿爾茨海默病 (AD) 和帕金森病 (PD) 的驅動因素。在肝病方面，其孤兒藥候選藥物 BIV201（持續輸注特利加壓素）正在進行 BIV201 的 3 期臨牀試驗，用於減少肝硬化和腹水患者的進一步失代償。
公司簡介
公司代碼BIVI
公司名稱BioVie Inc
上市日期Jan 14, 2014
CEOMr. Viet Cuong Do
員工數量14
證券類型Ordinary Share
年結日Jan 14
公司地址680 W Nye Lane
城市CARSON CITY
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編89703
電話17758883162
網址https://www.bioviepharma.com/
公司代碼BIVI
上市日期Jan 14, 2014
CEOMr. Viet Cuong Do
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Joseph M. Palumbo, M.D.
Dr. Joseph M. Palumbo, M.D.
Chief Medical Officer
Chief Medical Officer
1.09K
+902.75%
Ms. Joanne Wendy Kim, CPA
Ms. Joanne Wendy Kim, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
841.00
+901.19%
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Chairman of the Board
Independent Chairman of the Board
689.00
+898.55%
Mr. Michael Edward Sherman, J.D.
Mr. Michael Edward Sherman, J.D.
Independent Director
Independent Director
208.00
+890.48%
Mr. Richard J. Berman
Mr. Richard J. Berman
Independent Director
Independent Director
--
--
Mr. Viet Cuong Do
Mr. Viet Cuong Do
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sigmund (Sig) Rogich
Mr. Sigmund (Sig) Rogich
Independent Director
Independent Director
--
--
Ms. Amy Chappell, M.D.
Ms. Amy Chappell, M.D.
Director
Director
--
--
Mr. Kameel D. Farag
Mr. Kameel D. Farag
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Joseph M. Palumbo, M.D.
Dr. Joseph M. Palumbo, M.D.
Chief Medical Officer
Chief Medical Officer
1.09K
+902.75%
Ms. Joanne Wendy Kim, CPA
Ms. Joanne Wendy Kim, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
841.00
+901.19%
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Chairman of the Board
Independent Chairman of the Board
689.00
+898.55%
Mr. Michael Edward Sherman, J.D.
Mr. Michael Edward Sherman, J.D.
Independent Director
Independent Director
208.00
+890.48%
Mr. Richard J. Berman
Mr. Richard J. Berman
Independent Director
Independent Director
--
--
Mr. Viet Cuong Do
Mr. Viet Cuong Do
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月26日 週六
更新時間: 7月26日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Acuitas Group Holdings LLC
12.47%
The Vanguard Group, Inc.
2.89%
Geode Capital Management, L.L.C.
0.74%
Do Cuong Viet
0.31%
GWM Advisors LLC
0.29%
Other
83.29%
持股股東
持股股東
佔比
Acuitas Group Holdings LLC
12.47%
The Vanguard Group, Inc.
2.89%
Geode Capital Management, L.L.C.
0.74%
Do Cuong Viet
0.31%
GWM Advisors LLC
0.29%
Other
83.29%
股東類型
持股股東
佔比
Corporation
12.47%
Investment Advisor
4.51%
Investment Advisor/Hedge Fund
0.93%
Individual Investor
0.84%
Hedge Fund
0.15%
Research Firm
0.03%
Other
81.07%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
150
132.06K
7.11%
-381.94K
2025Q1
160
3.53M
36.23%
-1.67M
2024Q4
161
3.27M
17.78%
-55.97K
2024Q3
156
2.82M
17.58%
-327.33K
2024Q2
149
2.93M
48.15%
-286.77K
2024Q1
142
3.11M
175.46%
+382.36K
2023Q4
137
2.62M
70.26%
-64.72K
2023Q3
129
2.61M
70.37%
-91.05K
2023Q2
117
2.63M
74.62%
+3.43K
2023Q1
89
2.59M
74.46%
+69.39K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Acuitas Group Holdings LLC
231.63K
12.47%
-37.00
-0.02%
Jun 25, 2025
The Vanguard Group, Inc.
53.66K
2.89%
+44.64K
+494.42%
Mar 31, 2025
Geode Capital Management, L.L.C.
13.80K
0.74%
+1.46K
+11.84%
Mar 31, 2025
Do Cuong Viet
5.70K
0.31%
+864.00
+17.85%
May 30, 2025
GWM Advisors LLC
5.41K
0.29%
+4.00K
+283.69%
Mar 31, 2025
Swisspartners Investment Network AG
5.33K
0.29%
+2.33K
+77.60%
Jun 30, 2024
UBS Financial Services, Inc.
4.98K
0.27%
+148.00
+3.06%
Mar 31, 2025
Berman (Richard Jay)
4.06K
0.22%
+3.42K
+531.06%
Nov 20, 2024
Sanders Morris LLC
4.00K
0.22%
--
--
Mar 31, 2025
Rogich Sigmund A
2.13K
0.11%
-1.56K
-42.24%
May 30, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
0%
iShares Russell 2000 Growth ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
ProShares Hedge Replication ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
iShares Micro-Cap ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Global X Russell 2000 ETF
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
公告日期
類型
比率
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
